vs

Side-by-side financial comparison of DeFi Development Corp. (DFDV) and Protalix BioTherapeutics, Inc. (PLX). Click either name above to swap in a different company.

Protalix BioTherapeutics, Inc. is the larger business by last-quarter revenue ($9.1M vs $4.6M, roughly 2.0× DeFi Development Corp.). DeFi Development Corp. runs the higher net margin — 1211.4% vs -60.3%, a 1271.7% gap on every dollar of revenue. On growth, DeFi Development Corp. posted the faster year-over-year revenue change (647.2% vs -49.9%). Over the past eight quarters, DeFi Development Corp.'s revenue compounded faster (181.5% CAGR vs -6.7%).

Automotive Design and Development Ltd (ADD) was an English company responsible for the creation of the futuristic-looking Nova kit car. It was based in Southampton from 1971 to 1973 after which it moved to Accrington, Lancashire until 1975. ADD failed and the rights to the Nova were bought by Nova Cars in Mirfield, West Yorkshire in 1978, which continued until 1990. A low volume production run was made by Nova Developments in Cornwall in the 1990s and the company was sold to India-based Aerot...

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.

DFDV vs PLX — Head-to-Head

Bigger by revenue
PLX
PLX
2.0× larger
PLX
$9.1M
$4.6M
DFDV
Growing faster (revenue YoY)
DFDV
DFDV
+697.1% gap
DFDV
647.2%
-49.9%
PLX
Higher net margin
DFDV
DFDV
1271.7% more per $
DFDV
1211.4%
-60.3%
PLX
Faster 2-yr revenue CAGR
DFDV
DFDV
Annualised
DFDV
181.5%
-6.7%
PLX

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DFDV
DFDV
PLX
PLX
Revenue
$4.6M
$9.1M
Net Profit
$56.0M
$-5.5M
Gross Margin
98.1%
49.4%
Operating Margin
-51.1%
Net Margin
1211.4%
-60.3%
Revenue YoY
647.2%
-49.9%
Net Profit YoY
11995.1%
-184.8%
EPS (diluted)
$1.95
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DFDV
DFDV
PLX
PLX
Q4 25
$9.1M
Q3 25
$4.6M
$17.9M
Q2 25
$2.0M
$15.7M
Q1 25
$287.2K
$10.1M
Q4 24
$628.9K
$18.2M
Q3 24
$619.0K
$18.0M
Q2 24
$441.0K
$13.5M
Q1 24
$411.1K
Net Profit
DFDV
DFDV
PLX
PLX
Q4 25
$-5.5M
Q3 25
$56.0M
$2.4M
Q2 25
$15.4M
$164.0K
Q1 25
$-778.0K
$-3.6M
Q4 24
$-487.0K
$6.5M
Q3 24
$-471.0K
$3.2M
Q2 24
$-805.0K
$-2.2M
Q1 24
$-964.0K
Gross Margin
DFDV
DFDV
PLX
PLX
Q4 25
49.4%
Q3 25
98.1%
53.4%
Q2 25
98.6%
62.5%
Q1 25
19.1%
Q4 24
98.8%
78.7%
Q3 24
98.7%
53.4%
Q2 24
98.2%
29.8%
Q1 24
97.9%
Operating Margin
DFDV
DFDV
PLX
PLX
Q4 25
-51.1%
Q3 25
11.9%
Q2 25
7.5%
Q1 25
-307.5%
-41.0%
Q4 24
-107.9%
39.6%
Q3 24
-73.3%
22.2%
Q2 24
-193.2%
-18.0%
Q1 24
-247.7%
Net Margin
DFDV
DFDV
PLX
PLX
Q4 25
-60.3%
Q3 25
1211.4%
13.2%
Q2 25
777.0%
1.0%
Q1 25
-270.9%
-35.8%
Q4 24
-77.4%
35.6%
Q3 24
-76.1%
18.0%
Q2 24
-182.5%
-16.4%
Q1 24
-234.5%
EPS (diluted)
DFDV
DFDV
PLX
PLX
Q4 25
$-0.06
Q3 25
$1.95
$0.03
Q2 25
$0.84
$0.00
Q1 25
$-0.55
$-0.05
Q4 24
$0.55
$0.10
Q3 24
$-0.05
$0.03
Q2 24
$-0.08
$-0.03
Q1 24
$-0.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DFDV
DFDV
PLX
PLX
Cash + ST InvestmentsLiquidity on hand
$1.4M
$14.7M
Total DebtLower is stronger
$131.4M
Stockholders' EquityBook value
$243.8M
$48.2M
Total Assets
$480.0M
$82.3M
Debt / EquityLower = less leverage
0.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DFDV
DFDV
PLX
PLX
Q4 25
$14.7M
Q3 25
$1.4M
$13.6M
Q2 25
$595.0K
$17.9M
Q1 25
$2.2M
$19.5M
Q4 24
$2.8M
$19.8M
Q3 24
$2.8M
$27.4M
Q2 24
$3.2M
$23.4M
Q1 24
$3.9M
Total Debt
DFDV
DFDV
PLX
PLX
Q4 25
Q3 25
$131.4M
Q2 25
$21.2M
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DFDV
DFDV
PLX
PLX
Q4 25
$48.2M
Q3 25
$243.8M
$52.9M
Q2 25
$79.6M
$49.9M
Q1 25
$2.8M
$45.2M
Q4 24
$3.5M
$43.2M
Q3 24
$4.0M
$32.4M
Q2 24
$4.3M
$28.6M
Q1 24
$5.0M
Total Assets
DFDV
DFDV
PLX
PLX
Q4 25
$82.3M
Q3 25
$480.0M
$82.3M
Q2 25
$107.2M
$78.5M
Q1 25
$4.2M
$73.9M
Q4 24
$4.4M
$73.4M
Q3 24
$4.5M
$61.6M
Q2 24
$4.8M
$91.5M
Q1 24
$5.5M
Debt / Equity
DFDV
DFDV
PLX
PLX
Q4 25
Q3 25
0.54×
Q2 25
0.27×
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DFDV
DFDV
PLX
PLX
Operating Cash FlowLast quarter
$-5.0M
$2.0M
Free Cash FlowOCF − Capex
$1.6M
FCF MarginFCF / Revenue
17.8%
Capex IntensityCapex / Revenue
0.0%
4.4%
Cash ConversionOCF / Net Profit
-0.09×
TTM Free Cash FlowTrailing 4 quarters
$-13.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DFDV
DFDV
PLX
PLX
Q4 25
$2.0M
Q3 25
$-5.0M
$-3.7M
Q2 25
$-1.3M
$-5.2M
Q1 25
$-785.6K
$-5.1M
Q4 24
$-2.4M
$4.0M
Q3 24
$-412.0K
$4.1M
Q2 24
$-680.8K
$-3.6M
Q1 24
$-1.1M
Free Cash Flow
DFDV
DFDV
PLX
PLX
Q4 25
$1.6M
Q3 25
$-4.2M
Q2 25
$-5.7M
Q1 25
$-5.4M
Q4 24
$-2.4M
$3.6M
Q3 24
$4.0M
Q2 24
$-687.4K
$-3.8M
Q1 24
$-1.2M
FCF Margin
DFDV
DFDV
PLX
PLX
Q4 25
17.8%
Q3 25
-23.7%
Q2 25
-36.2%
Q1 25
-53.0%
Q4 24
-388.2%
19.6%
Q3 24
22.4%
Q2 24
-155.9%
-28.1%
Q1 24
-280.3%
Capex Intensity
DFDV
DFDV
PLX
PLX
Q4 25
4.4%
Q3 25
0.0%
2.8%
Q2 25
2.8%
Q1 25
3.0%
Q4 24
3.7%
2.3%
Q3 24
0.0%
0.5%
Q2 24
1.5%
1.3%
Q1 24
1.6%
Cash Conversion
DFDV
DFDV
PLX
PLX
Q4 25
Q3 25
-0.09×
-1.58×
Q2 25
-0.08×
-31.91×
Q1 25
Q4 24
0.61×
Q3 24
1.27×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DFDV
DFDV

Digital Asset Treasury$3.8M82%
Other$831.0K18%

PLX
PLX

Products$8.7M95%
Other$428.0K5%

Related Comparisons